Recipharm Pharmaservices Private Limited
FDA inspection history in Bengaluru, India, 2019 to 2020
- 2
- Form 483s
Every document, by year
- Form 483
2019: one Form 483; 2020: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019–20Two Form 483s, at Bengaluru, India.
- 2019The longest 483 on file: 3 observations over 3 pages at Bengaluru, India.
Cited most
Across all Recipharm Pharmaservices Private Limited observations on file
- 21 CFR 211.68Automatic, mechanical, and electronic equipment2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
The complete Recipharm Pharmaservices Private Limited file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Bengaluru, India
Two Form 483s · 2019 to 2020 · 4 observations
Latest: Form 483, Feb 13, 2020 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-02-13 | 483 Form 483 | Bengaluru, India | 1 | $99 |
| 2019-02-01 | 483 Form 483 | Bengaluru, India | 3 | $99 |
Investigators on these documents
FEI number 3009150119 · most recent document Feb 13, 2020
About Recipharm Pharmaservices Private Limited
How many FDA Form 483s has Recipharm Pharmaservices Private Limited received?
FDA Intel has 2 Form 483s on file for Recipharm Pharmaservices Private Limited; the most recent is dated Feb 13, 2020.
When was Recipharm Pharmaservices Private Limited last inspected by FDA?
The most recent FDA inspection document on file for Recipharm Pharmaservices Private Limited is a Form 483 dated Feb 13, 2020, for the site in Bengaluru, India.
What did FDA cite at Recipharm Pharmaservices Private Limited?
The regulations cited most in the observations on file for Recipharm Pharmaservices Private Limited are 21 CFR 211.68 (Automatic, mechanical, and electronic equipment), 2 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.113 (Control of microbiological contamination), 1 time.